Clinical Trial Update: Glioma Developmental and HyperActive Ras Tumor (DHART) Board

View source ↗

Summary

A clinical trial called Glioma Developmental and HyperActive Ras Tumor (DHART) is currently recruiting at Memorial Sloan Kettering Cancer Center for glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioma | Status: RECRUITING